Larson Financial Group
LENZ icon

Larson Financial Group’s LENZ Therapeutics LENZ Stock Holding History

Larson Financial Group’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-734
Closed -$4.17K – 4044
2026
Q2 		$4.17K Buy
734
+677
+1,188% +$5.46K ﹤0.01% 2850
2026
Q1 		$522 Buy
57
+44
+338% +$618 ﹤0.01% 3309
2025
Q4 		$208 Sell
13
-165
-93% -$4.81K ﹤0.01% 3265
2025
Q3 		$8.29K Buy
178
+18
+11% +$662 ﹤0.01% 2113
2025
Q2 		$4.69K Buy
160
+121
+310% +$3.29K ﹤0.01% 2095
2025
Q1 		$1K Buy
+39
New +$960 ﹤0.01% 2389

Other funds holding LENZ

Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Kestra Private Wealth Services
Kestra Private Wealth Services Austin, Texas $9.37B AUM 22.72% 1-Year Est. Return

Larson Financial Group's LENZ Position: Q3 2026 in Review

Larson Financial Group sold out of LENZ Therapeutics (LENZ) in Q3 2026, closing a stake of 734 shares — an estimated $4.17K sold.

Larson Financial Group first reported a position in LENZ in Q1 2025 and held it in 6 quarters. The position peaked at $8.29K in Q3 2025. 42 funds tracked by Wall St. Rank hold LENZ as of Q3 2026.

  • Larson Financial Group reported no remaining LENZ Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Larson Financial Group sold 734 LENZ Therapeutics shares in Q3 2026, an estimated $4.17K.
  • Larson Financial Group first reported a position in LENZ Therapeutics in Q1 2025 and held it in 6 quarters.
  • Larson Financial Group's LENZ Therapeutics position peaked at $8.29K in Q3 2025.
  • 42 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.